A recent study from Alzheimer’s disease researchers at the University of Wisconsin–Madison used neuroimaging technology called 4D Flow MRI to study the relationship between blood vessel disease and Alzheimer’s disease. Published in December 2021, the study found that people with Alzheimer’s disease symptoms had stiffer blood vessels in their brains, which could lead to inflammation and a buildup of Alzheimer’s biomarkers like amyloid and tau proteins. Lead researcher Leonardo Rivera-Rivera joins the podcast to discuss his findings, the developments made with new 4D Flow MRI scans, and how these developments could impact future Alzheimer’s disease research and clinical practices.
Guest: Leonardo Rivera-Rivera, PhD, neuroimaging scientist, Wisconsin Alzheimer’s Disease Research Center
Episode Topics8:55 How does the 4D Flow MRI technology used in your study compare to MRIs used in clinics?
13:18 What did you look at in your study? What were your findings?
17:54 Did you see more pronounced findings in particular individuals with APOE4 or other chronic conditions like diabetes?
20:37 Why is this an important finding for Alzheimer’s disease research? Do you think 4D flow MRIs could be incorporated into clinical settings?
Show NotesRead Leonardo Rivera-Rivera’s publication “Cerebrovascular stiffness and flow dynamics in the presence of amyloid and tau biomarkers,” published in the journal Alzheimer’s and Dementia: Diagnosis, Assessment & Disease Monitoring.
Learn more about Leonardo Rivera-Rivera’s research at the Wisconsin Alzheimer’s Disease Research Center website.
Mixed Dementia, Explained
The Case for Disclosing Biomarker Results to Alzheimer’s Research Participants
Promoting Open Science and Community Engagement with the National Institute on Aging
Moving into the Digital Era of Alzheimer’s Disease Research
National Efforts to Standardize Brain Scan Data for More Accurate Alzheimer’s Risk Predictions
Protecting Participant Privacy and Making Predictions Using Alzheimer’s Data
The Future of Sharing and Accessing Alzheimer’s Disease Data
Introducing the National Alzheimer’s Coordinating Center
Study Shows APOE e4 Not Associated with Alzheimer’s Disease in American Indian Populations
Improving Registries and Representation in Alzheimer’s Disease Research
Highlights from the 2022 Alzheimer’s Association International Conference
COVID-19 and Its Effects on the Brain
Apathy and Alzheimer’s Disease: Plenary Preview with Dr. Krista Lanctôt
Scientific Importance of Diversity in Alzheimer’s Disease Research
Delirium and Dementia: Plenary Preview with Dr. Sharon Inouye
Non-Pharmacological Care for People with MCI and Dementia: Plenary Preview with Dr. Linda Lam
Opening Doors to Research Participants: Making Scientific Conferences Accessible to the Public
The World’s Largest Forum for Alzheimer’s Research: Introducing the AAIC 2022 Special Series
Study Shows Do-Not-Resuscitate Orders Can Lead to Worse Care, Increase Death Rates
‘Finding the Right Words’: Author Interview with Cindy Weinstein and Bruce Miller
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Life in the A-Zone
Caregiver Storyteller - About Alzheimer’s and Dementia Caregiving
The Life, Love, and Alzheimer’s Podcast
Fading Memories: Alzheimer’s/Dementia Caregiver Support
Alzheimer’s Speaks